Cargando…
Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review
Sepsis remains a common cause of death in intensive care units, accounting for approximately 20% of total deaths worldwide. Its pathogenesis is partly attributable to dysregulated inflammatory responses to bacterial endotoxins (such as lipopolysaccharide, LPS), which stimulate innate immune cells to...
Autores principales: | Zhu, Cassie Shu, Wang, Wei, Qiang, Xiaoling, Chen, Weiqiang, Lan, Xiqian, Li, Jianhua, Wang, Haichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469563/ https://www.ncbi.nlm.nih.gov/pubmed/34571869 http://dx.doi.org/10.3390/cells10092220 |
Ejemplares similares
-
Identification of procathepsin L (pCTS-L)–neutralizing monoclonal antibodies to treat potentially lethal sepsis
por: Zhu, Cassie Shu, et al.
Publicado: (2023) -
Development of Procathepsin L (pCTS-L)-Inhibiting Lanosterol-Carrying Liposome Nanoparticles to Treat Lethal Sepsis
por: Chen, Weiqiang, et al.
Publicado: (2023) -
Regulation of HMGB1 Release in Health and Diseases
por: Wang, Haichao
Publicado: (2022) -
Therapeutic potential of HMGB1-targeting agents in sepsis
por: Wang, Haichao, et al.
Publicado: (2008) -
PKM2 Regulates the Warburg Effect and Promotes HMGB1 Release in Sepsis
por: Yang, Liangchun, et al.
Publicado: (2014)